Luhao Li
No. 1 East Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
circ_0046599 Promotes HCC Progression by Competing with miR-1322 to Enhance NT5DC2 Expression.
Journal: Journal of Cancer
Published: September 14, 2024
A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 15, 2023
Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: October 21, 2022
GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
Journal: Biochemical and biophysical research communications
Published: July 10, 2022
Severe hyponatraemia with neurological manifestations in patients treated with terlipressin: Two case reports.
Journal: Journal of clinical pharmacy and therapeutics
Published: June 13, 2019
Analysis of risk factors of Budd-Chiari syndrome complicated with hepatocellular carcinoma
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: September 12, 2015
Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.
Journal: International journal of clinical and experimental medicine
Published: March 02, 2015
Research status of Budd-Chiari syndrome in China.
Journal: International journal of clinical and experimental medicine
Published: September 23, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026